Jefferies Initiates DENTSPLY At Buy (XRAY)

Analysts at Jefferies have initiated coverage of DENTSPLY International XRAY with a Buy rating and $40 price target. During today's trading session, the shares have gained 0.37% to $32.23. The analysts wrote that "we believe XRAY should be able to leverage its massive distribution network, marketing platform, and R&D capabilities to sell higher value-added products, which should enhance margins and drive stronger cash flows. We view its opportunity to stimulate its earnings profile through accelerated capital deployment activities as under-appreciated at current valuations." DENTSPLY International Inc (DENTSPLY) is a designer, developer, manufacturer and marketer of a range of products for the dental market. The Company conducts its business through four operating segments, all of which are primarily engaged in the design, manufacture and distribution of dental products in three principal categories: dental consumables, dental laboratory products and dental specialty products.